NADPH oxidase 1 overexpression enhances invasion via matrix metalloproteinase-2 and epithelial-mesenchymal transition in melanoma cells

Journal of Investigative Dermatology

Volumn 132, Issue 8, 2012, Pages 2033-2041

  Liu, Feng ^a,b   Gomez Garcia, Angela M ^b   Meyskens, Frank L ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UVOMORULIN;

ARTICLE; BIOACCUMULATION; CANCER INVASION; CELL INVASION; CELL MEMBRANE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MELANOCYTE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SUBUNIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84863990088     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.119     Document Type: Article

References (52)

1. Ambasta RK, Kumar P, Griendling KK et al. (2004) Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279:45935-41
2. Banfi B, Schrenzel J, Nusse O et al. (1999) A novel H(+) conductance in eosinophils: unique characteristics and absence in chronic granulomatous disease. J Exp Med 190:183-94
3. Bergman MR, Cheng S, Honbo N et al. (2003) A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J 369:485-96
4. Blavier L, Lazaryev A, Shi XH et al. (2010) Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT). Cancer Biol Ther 10:198-208
5. Brar SS, Kennedy TP, Sturrock AB et al. (2002) An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol 282:C1212-24
6. Brown DI, Griendling KK (2009) Nox proteins in signal transduction. Free Radic Biol Med 47:1239-53
7. Cai H, Dikalov S, Griendling KK et al. (2007) Detection of reactive oxygen species and nitric oxide in vascular cells and tissues: comparison of sensitivity and specificity. Methods Mol Med 139:293-311
8. Cui XL, Douglas JG (1997) Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA 94:3771-6
9. Flesch FM, Voorhout WF, Colenbrander B et al. (1998) Use of lectins to characterize plasma membrane preparations from boar spermatozoa: a novel technique for monitoring membrane purity and quantity. Biol Reprod 59:1530-9
10. Fried L, Arbiser JL (2008) The reactive oxygen-driven tumor: relevance to melanoma. Pigment Cell Melanoma Res 21:117-22
11. Giannopoulou C, Krause KH, Muller F (2008) The NADPH oxidase NOX2 plays a role in periodontal pathologies. Semin Immunopathol 30: 273-278
12. Govindarajan B, Sligh JE, Vincent BJ et al. (2007) Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J Clin Invest 117:719-29
13. Hadler-Olsen E, Fadnes B, Sylte I et al. (2010) Regulation of matrix metalloproteinase activity in health and disease. FEBS J 278:28-45
14. Hanna IR, Hilenski LL, Dikalova A et al. (2004) Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med 37:1542-9
15. Kajanne R, Miettinen P, Mehlem A et al. (2007) EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J Cell Physiol 212:489-97
16. Kamata T (2009) Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci 100:1382-8
17. Kawahara T, Lambeth JD (2007) Molecular evolution of Phox-related regulatory subunits for NADPH oxidase enzymes. BMC Evol Biol 7:178
18. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52-67
19. Kim EY, Seo JM, Cho KJ et al. (2009) Ras-induced invasion and metastasis are regulated by a leukotriene B4 receptor BLT2-linked pathway. Oncogene 29:1167-78
20. Komarov DA, Slepneva IA, Glupov VV et al. (2005) Superoxide and hydrogen peroxide formation during enzymatic oxidation of DOPA by phenoloxidase. Free Radic Res 39:853-8
21. Komatsu D, Kato M, Nakayama J et al. (2008) NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene 27:4724-32
22. Krause KH, Bedard K (2008) NOX enzymes in immuno-inflammatory pathologies. Semin Immunopathol 30:193-4
23. Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181-9
24. Leslie MC, Bar-Eli M (2005) Regulation of gene expression in melanoma: new approaches for treatment. J Cell Biochem 94:25-38
25. Lin CY, Tsai PH, Kandaswami CC et al. (2011) Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci 102:815-27
26. Liu F, Fu Y, Meyskens Jr FL (2009) MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J Invest Dermatol 129:422-31
27. Liu F, Lee WH (2006) CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression. Mol Cell Biol 26:3124-34
28. Liu F, Singh A, Yang Z et al. (2010) MiTF links Erk1/2 kinase and p21 CIP1/WAF1 activation after UVC radiation in normal human melanocytes and melanoma cells. Mol Cancer 9:214
29. Malaponte G, Zacchia A, Bevelacqua Y et al. (2010) Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-beta in melanoma development and progression. Oncol Rep 24:81-7
30. Meyskens Jr FL, Chau HV, Tohidian N et al. (1997) Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigment Cell Res 10:184-9
31. Orimoto AM, Neto CF, Pimentel ER et al. (2008) High numbers of human skin cancers express MMP2 and several integrin genes. J Cutan Pathol 35: 285-91
32. Pla P, Moore R, Morali OG et al. (2001) Cadherins in neural crest cell development and transformation. J Cell Physiol 189:121-32
33. Rada B, Hably C, Meczner A et al. (2008) Role of Nox2 in elimination of microorganisms. Semin Immunopathol 30:237-53
34. Radisky DC, Levy DD, Littlepage LE et al. (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436:123-7
35. Sadok A, Pierres A, Dahan L et al. (2009) NADPH oxidase 1 controls the persistence of directed cell migration by a Rho-dependent switch of alpha2/alpha3 integrins. Mol Cell Biol 29:3915-28
36. Sander CS, Hamm F, Elsner P et al. (2003) Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 148:913-22
37. Shinohara M, Adachi Y, Mitsushita J et al. (2010) Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration. J Biol Chem 285:4481-8
38. Simonetti O, Lucarini G, Brancorsini D et al. (2002) Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Cancer 95:1963-70
39. Singh A, Settleman J (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29:4741-51
40. Singh NK, Quyen DV, Kundumani-Sridharan V et al. (2010) AP-1 (Fra-1/c-Jun)-mediated induction of expression of matrix metalloproteinase-2 is required for 15S-hydroxyeicosatetraenoic acid-induced angiogenesis. J Biol Chem 285:16830-43
41. Slominski A, Tobin DJ, Shibahara S et al. (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84:1155-228
42. Suh YA, Arnold RS, Lassegue B et al. (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79-82
43. Sumimoto H (2008) Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J 275: 3249-77
44. Tan TK, Zheng G, Hsu TT et al. (2010) Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 176:1256-70
45. Vaisanen A, Kallioinen M, Taskinen PJ et al. (1998) Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. J Pathol 186:51-8
46. Vaisanen AH, Kallioinen M, Turpeenniemi-Hujanen T (2008) Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma. Hum Pathol 39:377-85
47. van den Oord JJ, Paemen L, Opdenakker G et al. (1997) Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 151:665-70
48. Wittgen HG, van Kempen LC (2007) Reactive oxygen species in melanoma and its therapeutic implications. Melanoma Res 17:400-9
49. Yamanishi DT, Buckmeier JA, Meyskens Jr FL (1991) Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas. J Invest Dermatol 97:349-53
50. Yamaura M, Mitsushita J, Furuta S et al. (2009) NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res 69:2647-54
51. Yang S, Meyskens Jr FL (2005) Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma. Mol Pharmacol 67:298-308
52. Zhao Y, Liu J, McMartin KE (2008) Inhibition of NADPH oxidase activity promotes differentiation of B16 melanoma cells. Oncol Rep 19:1225-30